6Maddrey WC,Schiff ER,Sorrell MF:Transplantation of the liver.3rd ed.Lippincon Williams Wilkins,2001.5. 被引量：1
7Wu YM, Voigt M, Rayhill S, et al. Suprahepatic venacavaplasty(cavaplasty) with retrohepatic cava extension in liver transplantation,2001,72(8) :1389. 被引量：1
9Arroyo V,Gines P,Gerbes AL,et al. Definition and cliagnostic Criteria of refractory ascites and Hepatorenal Syndrom in cirrhosis. Hepatology, 1996,23 ( 1 ) :164. 被引量：1
10Moser MA. Options for induction immunosuppression in liver transplant recipients. Drugs,2002,62 ( 7 ) : 995. 被引量：1
二级参考文献17
1[1]Neuhaus P,Jonas S,Bechstein WO,et al .Liver transplantation for hepato cellular carcinoma.Transplant Proc ,1999,31:469-71. 被引量：1
2[2]Ringe B,Wittekind C,Bechstein WO,et al. The role of liver transplantat ion in hepatobiliary malignancy.Ann Surg,1989,209:88-93. 被引量：1
3[3]Pann I.Hepatic transplantation for primary and metastatic cancersof li ver.Surgery,1991,110:726-734. 被引量：1
4[4]Lau WY,Leung TW,Ho SK,et al.Adijvant intra-arterial iodine-131-laba lle d lipiodol for resectable hepatocellular carcinoma:a prospective randomized tria l.Lancet ,1999,353:797-801. 被引量：1
6[6]Mazzaferro V,Regalia E,Doci R,et al.Livr transplantation for treatment of small hepatocellular carcinomas in patients with cirrhosis.N Engl M ed,1996,334:693-699. 被引量：1
7[7]Mor E,Kaspa RT,Sheiner P,et al.Treatment of hepatocellular carcino ma associated with cirrhosis in the era of liver transplantation.Ann In tern Med,1998,129:643-53. 被引量：1
8[8]Llovet JM,Bruix J,Gores GJ.Surgical resection versus transplantation f or early hepatocellular carcinoma:clues for the best strategy.Hepatolog y,2000,31:1019-21. 被引量：1
9[9]Esquivel CO,Keeffe EB,Garcia G,et al.Resection versus transplantation for hepatocellular carcinoma.J Gastroenterol Hepatol,1999,14 S uppl:37-41. 被引量：1
10[1]Navarro F,Le Moino MC,Fabre JM,et al.Specific vascular complications of orthotopic liver transplantation with preservation of the retrohepatic vena cava:review of 1361 cases.Transplantation,1999,68(5):646 被引量：1
3[4]Patel R.Association between nasal methicillin-resistant Staphylococcus aureus carriage and infection in liver transplant recipients[J].Liver Transpl,2001,7(8):752. 被引量：1
4[7]Ghany MG,Ayola B,Villamil FG,et al.Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globuslin prophylaxis[J].Hepatology,1998,27:213. 被引量：1
5Patel R. Association between nasal methicillin -resistant Staphylococcus aureus carriage and infection in liver transplant recipients [ J ].Liver Transpl, 2001, 7 (8): 752. 被引量：1
6Ghany MG, Ayola B, Villamil FG, et al.Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globuslin prophylaxis [J ]. Hepatology, 1998, 27: 213. 被引量：1
7Singh N.Infectious diseases in the live transplant recipient[J].Semin Gastrointest Dis,1998,(3):136-146. 被引量：1
